Quintiles Transnational Corp. - Strategic SWOT Analysis Review by GlobalData

VIEWS: 126 PAGES: 34

More Info
									            Quintiles Transnational Holdings Inc. (Q) - Strategic SWOT Analysis
                                          Review
        Reference Code: GDPH40184SA                                                                                          Publication Date: JUL 2013

          4820 Emperor Boulevard                             Phone             +1 919 9982000                   Revenue         4,865.5 (million USD)
          Durham, NC                                         Fax               +1 919 9982003                   Net Profit      NA
          27703                                              Website           www.quintiles.com                Employees       27,412
                                                                               Q [New York           Stock                      Pharmaceuticals         &
          United States                                      Exchange                                           Industry
                                                                               Exchange]                                        Healthcare

       Company Overview
       Quintiles Transnational Holdings Inc. (Quintiles) is one of the largest contract research organizations and a provider of
       biopharmaceutical services. It caters to the needs of biopharmaceutical companies and other healthcare organizations including
       payers and providers. The company’s service portfolio includes clinical trials, product development services and integrated
       healthcare services. Quintiles conducts clinical trials on behalf of its clients and provides clinical trial management services; and
       helps optimize drug development.
       Key Executives                                                             SWOT Analysis
                     Name                                Title                     Quintiles Transnational Holdings Inc., SWOT Analysis
         Dennis B. Gillings, Ph.D.         Chairman                                Strengths                            Weaknesses
         John D. Ratliff                   Chief Operating Officer
                                                                                                                        Legal Issues
         Thomas H. Pike                    Chief Executive Officer                 Consistent Growth in Revenue
                                                                                                                        Therapeutic and Customer
         Fred E. Cohen, M.D.               Director                                Industry Recognition
                                                                                                                        Concentration
         John P. Connaughton               Director
        Source: Company Website, Primary and Secondary Research,
        GlobalData                                                                 Opportunities                        Threats

                                                                                   Market Potential: Outsourcing        Global Economic Scenario
        Key Competitors                                                            Business
         PRA International                                                                                              Competitive Environment
                                                                                   Acquisitions-Growth
         INC Research, LLC                                                         Opportunity
         ICON plc
         inVentiv Health, Inc
                                                                                  Source: Company Website, Primary and Secondary Research, GlobalData
        Pharmaceutical Product Development, LLC
        Source: Company Website, Primary and Secondary Research,
        GlobalData


       Recent Developments

       Jul 01, 2013                  Quintiles’ Second Quarter 2013 Earnings Call Scheduled for Thursday, August 1st
       May 15, 2013                  Merck Serono And Quintiles Announce Innovative Clinical Development Partnership
       Dec 13, 2012                  Quintiles Central Labs Receives Accreditation From CAP Biorepository Accreditation Program
       Nov 26, 2012                  Clinical Research Advantage And Quintiles Form Strategic Alliance To Improve Efficiency And Safety Of
                                     Clinical Studies
       Oct 23, 2012                  Quintiles Expands Patient Access For Clinical Trials To Indonesia
       Source: Annual Report, Company Website, Primary and Secondary Research, GlobalData




Quintiles Transnational Holdings Inc. (Q) - Strategic SWOT                                                                     Reference Code: GDPH40184SA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                  Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Quintiles Transnational Holdings Inc. - Key Facts .............................................................................................................................. 5
       Quintiles Transnational Holdings Inc. - Key Employees ..................................................................................................................... 6
       Quintiles Transnational Holdings Inc. - Key Employee Biographies ................................................................................................... 8
       Quintiles Transnational Holdings Inc. - Major Products and Services .............................................................................................. 10
       Quintiles Transnational Holdings Inc. - History ................................................................................................................................. 12
       Quintiles Transnational Holdings Inc. - Company Statement ........................................................................................................... 17
       Quintiles Transnational Holdings Inc. - Locations And Subsidiaries ................................................................................................. 19
          Head Office ................................................................................................................................................................................... 19
          Other Locations & Subsidiaries ..................................................................................................................................................... 19
       Section 2 – Company Analysis ......................................................................................................................................................... 27
       Quintiles Transnational Holdings Inc. - Business Description........................................................................................................... 27
       Quintiles Transnational Holdings Inc. - Corporate Strategy .............................................................................................................. 29
       Quintiles Transnational Holdings Inc. - SWOT Analysis ................................................................................................................... 30
          SWOT Analysis - Overview........................................................................................................................................................... 30
          Quintiles Transnational Holdings Inc. - Strengths ......................................................................................................................... 30
             Strength - Consistent Growth in Revenue ................................................................................................................................. 30
             Strength - Industry Recognition ................................................................................................................................................. 30
             Strength - Wide Geographical Base .......................................................................................................................................... 30
             Strength - Extensive Range of Pharmaceutical Services .......................................................................................................... 31
          Quintiles Transnational Holdings Inc. - Weaknesses .................................................................................................................... 31
             Weakness - Legal Issues .......................................................................................................................................................... 31
             Weakness - Therapeutic and Customer Concentration ............................................................................................................. 31
          Quintiles Transnational Holdings Inc. - Opportunities ................................................................................................................... 31
             Opportunity - Market Potential: Outsourcing Business .............................................................................................................. 31
             Opportunity - Acquisitions-Growth Opportunity ......................................................................................................................... 32
             Opportunity - Strategic Collaborations and Agreements ........................................................................................................... 32
          Quintiles Transnational Holdings Inc. - Threats ............................................................................................................................ 32
             Threat - Global Economic Scenario........................................................................................................................................... 32
             Threat - Competitive Environment ............................................................................................................................................. 32
             Threat - Stringent Government Regulations .............................................................................................................................. 33
       Quintiles Transnational Holdings Inc. - Key Competitors ................................................................................................................. 34
       Section 3 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 35
          Quintiles Transnational Holdings Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .................................. 35
          Quintiles Transnational Holdings Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 ................................. 36
       Quintiles Transnational Holdings Inc., Recent Deals Summary ....................................................................................................... 37
       Section 4 – Company’s Recent Developments ................................................................................................................................ 38
          Quintiles Transnational Holdings Inc., Recent Developments ...................................................................................................... 38
             Jul 01, 2013: Quintiles’ Second Quarter 2013 Earnings Call Scheduled for Thursday, August 1st ........................................... 38
             May 15, 2013: Merck Serono And Quintiles Announce Innovative Clinical Development Partnership ...................................... 38
             Dec 13, 2012: Quintiles Central Labs Receives Accreditation From CAP Biorepository Accreditation Program....................... 38




Quintiles Transnational Holdings Inc. (Q) - Strategic SWOT                                                                                                       Reference Code: GDPH40184SA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
             Nov 26, 2012: Clinical Research Advantage And Quintiles Form Strategic Alliance To Improve Efficiency And Safety Of
             Clinical Studies .......................................................................................................................................................................... 39
             Oct 23, 2012: Quintiles Expands Patient Access For Clinical Trials To Indonesia .................................................................... 39
             Sep 30, 2012: Quintiles, Scottish Health Boards Partner To Accelerate Clinical Research And Improve Health Outcomes .... 40
             Sep 20, 2012: Quintiles Unveils Next Generation Of Quintiles Infosario ................................................................................... 40
             Jun 26, 2012: Merck Serono Announces First Employment Initiative For Employees Affected By Restructuring In Switzerland
             .................................................................................................................................................................................................. 41
             Jun 18, 2012: Quintiles Expands Operations In China ..................................................................................................
								
To top